Joel Martinez

FDA investigator

Appears on 7 documents from 2002 to 2014, mostly at sites in Texas. Most often cites general requirements (21 CFR 211.80(a)).

7
Documents on file
6.3
Observations per 483
2002
First seen
2014
Most recent

What they cite most

From 25 observations

Activity by year

2002: 1, 2006: 1, 2012: 1, 2013: 3, 2014: 1

Where

Texas 6 · Maryland 1

Is Joel Martinez coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Alcon Research LLCJul 24, 2014 · Fort Worth, Texas
Warning letter Warning letter, Dec 3, 2013Dec 3, 2013 · Houston, Texas
483 Burzynski Research InstituteMar 15, 2013 · Houston, Texas
483 Stanislaw R Burzynski, M.DMar 15, 2013 · Houston, Maryland
483 Celltex Therapeutics CorporationApr 27, 2012 · Sugarland, Texas
Warning letter MD Anderson Cancer CenterMay 15, 2006 · Houston, Texas
Warning letter Burzynski Research InstituteApr 29, 2002 · Houston, Texas

About this profile

What does Joel Martinez inspect?

Joel Martinez appears on 7 documents on file covering 4 sites, mostly in Texas.

What do they cite most often?

21 CFR 211.80(a) (general requirements), followed by 21 CFR 211.192 and 21 CFR 312.62(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Joel Martinez is dated Jul 24, 2014.